Louis Vignati

3.0k total citations
24 papers, 1.8k citations indexed

About

Louis Vignati is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Ophthalmology. According to data from OpenAlex, Louis Vignati has authored 24 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Molecular Biology and 4 papers in Ophthalmology. Recurrent topics in Louis Vignati's work include Diabetes Management and Research (14 papers), Diabetes Treatment and Management (10 papers) and Retinal Imaging and Analysis (4 papers). Louis Vignati is often cited by papers focused on Diabetes Management and Research (14 papers), Diabetes Treatment and Management (10 papers) and Retinal Imaging and Analysis (4 papers). Louis Vignati collaborates with scholars based in United States, United Kingdom and Denmark. Louis Vignati's co-authors include Aniz Girach, James H. Anderson, Richard D. DiMarchi, Michael Trautmann, Rocco L. Brunelle, Edward J. Bastyr, Veikko A Koivisto, Lloyd Paul Aiello, Matthew D. Davis and Matthew J. Sheetz and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Cell Metabolism.

In The Last Decade

Louis Vignati

24 papers receiving 1.7k citations

Peers

Countries citing papers authored by Louis Vignati

Since Specialization

Citations

This map shows the geographic impact of Louis Vignati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louis Vignati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louis Vignati more than expected).

Fields of papers citing papers by Louis Vignati

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louis Vignati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louis Vignati. The network helps show where Louis Vignati may publish in the future.

Co-authorship network of co-authors of Louis Vignati

This figure shows the co-authorship network connecting the top 25 collaborators of Louis Vignati. A scholar is included among the top collaborators of Louis Vignati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louis Vignati. Louis Vignati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Sustained Effects of a Dual GIP/GLP-1 Receptor Agonist, NNC0090-2746, in Patients with Type 2 Diabetes 2017 ·Cell Metabolism ·Juan P. Frías, Edward J. Bastyr, Louis Vignati, Matthias H. Tschöp, Christophe Schmitt, (unknown), Rune Haubo Bojesen Christensen, Richard D. DiMarchi	257
2	ORAL PROTEIN KINASE C β INHIBITION USING RUBOXISTAURIN 2011 ·Retina ·Lloyd Paul Aiello, Louis Vignati, Matthew J. Sheetz, (unknown), Aniz Girach, Matthew D. Davis, Anne M. Wolka, (unknown), Roy C. Milton	77
3	Effect of Ruboxistaurin on the Visual Acuity Decline Associated with Long-standing Diabetic Macular Edema 2009 ·Investigative Ophthalmology & Visual Science ·Matthew D. Davis, Matthew J. Sheetz, Lloyd Paul Aiello, Roy C. Milton, Ronald P. Danis, (unknown), Aniz Girach, (unknown), Louis Vignati	64
4	Sustained moderate visual loss as a predictive end point for visual loss in non-proliferative diabetic retinopathy 2008 ·Eye ·(unknown), Aniz Girach, Lloyd Paul Aiello, R. C. Milton, Matthew D. Davis, Ronald P. Danis, Xu–Ting Zhi, Matthew J. Sheetz, Louis Vignati	4
5	Diabetic microvascular complications—can the presence of one predict the development of another? 2006 ·Journal of Diabetes and its Complications ·Aniz Girach, Louis Vignati	97
6	Factors associated with nocturnal hypoglycaemia among patients with type 2 diabetes new to insulin therapy: experience with insulin lispro 2000 ·Diabetes Obesity and Metabolism ·Edward J. Bastyr, Yijian Huang, Rocco L. Brunelle, Louis Vignati, Daniel J. Cox, James G. Kotsanos	23
7	Insulin lispro in the treatment of patients with type 2 diabetes mellitus after oral agent failure 1999 ·Clinical Therapeutics ·Edward J. Bastyr, Martin Johnson, Michael Trautmann, James H. Anderson, Louis Vignati	43
8	Basal activity profiles of NPH and [N ε -palmitoyl Lys (B29)] human insulins in subjects with IDDM 1998 ·Diabetologia ·J. Radziuk, Susan Pye, Brenda Bradley, Jan T. Braaten, Louis Vignati, Paris Roach, Ronald R. Bowsher, Richard D. DiMarchi, Ronald E. Chance	20
9	Efficacy of insulin lispro in combination with NPH human insulin twice per day in patients with insulin-dependent or non—insulin-dependent diabetes mellitus 1997 ·Clinical Therapeutics ·Louis Vignati, James H. Anderson, Philip W. Iversen	43
10	1.P.89 Mechanism of hypertriglyceridemia in human apolipoprotein A-IMilano transgenic mice 1997 ·Atherosclerosis ·Cinzia Parolini, (unknown), (unknown), Louis Vignati, Guido Franceschini, (unknown), Giulia Chiesa	1
11	Reduction of Postprandial Hyperglycemia and Frequency of Hypoglycemia in IDDM Patients on Insulin-Analog Treatment 1997 ·Diabetes ·James H. Anderson, Rocco L. Brunelle, Veikko A Koivisto, Andreas Pfützner, Michael Trautmann, Louis Vignati, Richard D. DiMarchi	263
12	Health-Related Quality-of-Life Results From Multinational Clinical Trials of Insulin Lispro: Assessing benefits of a new diabetes therapy 1997 ·Diabetes Care ·James G. Kotsanos, Louis Vignati, William J. Huster, (unknown), (unknown), Alan M. Jacobson, David G. Marrero, Susan D. Mathias, Donald L. Patrick, (unknown), James H. Anderson	101
13	Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group. 1997 ·PubMed ·James H. Anderson, Rocco L. Brunelle, P.P. Keohane, Veikko A Koivisto, Michael Trautmann, Louis Vignati, Richard D. DiMarchi	47
14	Pre-meal Insulin Analogue Insulin Lispro vs Humulin® R Insulin Treatment in Young Subjects with Type 1 Diabetes 1996 ·Diabetic Medicine ·Satish K. Garg, (unknown), (unknown), (unknown), Louis Vignati, (unknown), H. Peter Chase	74
15	The Antidiabetogenic Effect of GLP-1 Is Maintained During a 7-Day Treatment Period and Improves Diabetic Dyslipoproteinemia in NIDDM Patients 1996 ·Diabetes Care ·Lisa Juntti‐Berggren, Jan Pigon, Fredrik Karpe, Anders Hamsten, M. Gutniak, Louis Vignati, Suad Efendić	59
16	Insulin lispro improved postprandial glucose control and reduced hypoglycemia rate in type I diabetes 1995 ·James H. Anderson, Rocco L. Brunelle, Louis Vignati	4
17	Hypogonadotropic secondary amenorrhea in diabetes: Effects of central opiate blockade and improved metabolic control 1987 ·The American Journal of Medicine ·James A. O’Hare, (unknown), Louis Vignati	21
18	Insulin pumps: when are they indicated, what can they do? 1985 ·PubMed ·Louis Vignati	2
19	Insulin pumps. The patients' verdict. 1984 ·PubMed ·(unknown), Louis Vignati, (unknown)	4
20	Insulin Pumps: The Patients' Verdict 1984 ·AJN American Journal of Nursing ·(unknown), Louis Vignati, Sylvia Brown	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact